97 related articles for article (PubMed ID: 1425287)
1. [Ergotamine-induced heart valve fibrosis and coronary microangiopathy?].
Creutzig A
Dtsch Med Wochenschr; 1992 Nov; 117(45):1736. PubMed ID: 1425287
[No Abstract] [Full Text] [Related]
2. [Ergotamine-induced heart valve fibrosis].
Faber L
Dtsch Med Wochenschr; 1993 Feb; 118(6):205. PubMed ID: 8436073
[No Abstract] [Full Text] [Related]
3. Cardiac surgery for ergotamine-induced multivalvular heart disease.
Lazopoulos G; Papaioannou G; Kantartzis M
Thorac Cardiovasc Surg; 2013 Aug; 61(5):435-7. PubMed ID: 23475795
[TBL] [Abstract][Full Text] [Related]
4. From headache to heartache: ergotamine-induced aortic and mitral valvulopathy.
Patel SM; Ohori NP; Badhwar V; Cavalcante JL
J Am Coll Cardiol; 2013 Dec; 62(22):2144. PubMed ID: 24067402
[No Abstract] [Full Text] [Related]
5. Aortic and mitral valve disease induced by ergotamine therapy for migraine: a case report and review of the literature.
Hendrikx M; Van Dorpe J; Flameng W; Daenen W
J Heart Valve Dis; 1996 Mar; 5(2):235-7. PubMed ID: 8665020
[TBL] [Abstract][Full Text] [Related]
6. Mitral and aortic valve disease associated with ergotamine therapy for migraine. Report of two cases and review of literature.
Hauck AJ; Edwards WD; Danielson GK; Mullany CJ; Bresnahan DR
Arch Pathol Lab Med; 1990 Jan; 114(1):62-4. PubMed ID: 2403780
[TBL] [Abstract][Full Text] [Related]
7. Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations.
Redfield MM; Nicholson WJ; Edwards WD; Tajik AJ
Ann Intern Med; 1992 Jul; 117(1):50-2. PubMed ID: 1596047
[No Abstract] [Full Text] [Related]
8. [Letter: Coronary spasm following ergotamine medication].
Schwalb H
MMW Munch Med Wochenschr; 1975 Sep; 117(36):1437. PubMed ID: 809691
[No Abstract] [Full Text] [Related]
9. [Fibrosis and fusion of the heart valve].
Ohkawa S
Kokyu To Junkan; 1993 Mar; 41(3):201-7. PubMed ID: 8469824
[No Abstract] [Full Text] [Related]
10. Drugs for migraine.
Med Lett Drugs Ther; 1976 Jun; 18(13):55-6. PubMed ID: 934019
[No Abstract] [Full Text] [Related]
11. Development of endocardial valvuloids with valvular insufficiency.
Hutchins GM; Maron BJ
Arch Pathol; 1972 May; 93(5):401-7. PubMed ID: 5020689
[No Abstract] [Full Text] [Related]
12. [Valvular heart disease associated with ergotamine].
Martínez Quintana E; Llorens León R; Redondo Martínez E; Nieto Lago V; Jiménez Cabrera F; Gross Kastanovitz E
Rev Esp Cardiol; 2005 Jan; 58(1):97-9. PubMed ID: 15680136
[TBL] [Abstract][Full Text] [Related]
13. Images in clinical medicine. Four artificial heart valves.
Bijl M; van den Brink RB
N Engl J Med; 2005 Aug; 353(7):712. PubMed ID: 16107624
[No Abstract] [Full Text] [Related]
14. [Cardiac valve diseases: morphological characteristics and differential diagnosis].
Arkh Patol; 2007; 69(1):24-31. PubMed ID: 19385131
[TBL] [Abstract][Full Text] [Related]
15. Natural history of chronic valvular disease.
Stapleton JF
Cardiovasc Clin; 1986; 16(2):105-47. PubMed ID: 3742519
[No Abstract] [Full Text] [Related]
16. Morphological aspects of valvular heart disease: Part I.
Waller BF
Curr Probl Cardiol; 1984 Oct; 9(7):1-66. PubMed ID: 6488868
[No Abstract] [Full Text] [Related]
17. Mitral, aortic and tricuspid valvular heart disease associated with ergotamine therapy for migraine.
Wilke A; Hesse H; Hufnagel G; Maisch B
Eur Heart J; 1997 Apr; 18(4):701. PubMed ID: 9129909
[No Abstract] [Full Text] [Related]
18. Fibrosis due to ergot derivatives: exposure to risk should be weighed up.
Prescrire Int; 2002 Dec; 11(62):186-9. PubMed ID: 12472101
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of operatively excised cardiac valves: etiologic determination of valvular heart disease.
Waller BF; Bloch T; Barker BG; Roe SJ; Brown JW; Mahomed Y
Cardiol Clin; 1984 Nov; 2(4):687-716. PubMed ID: 6544649
[TBL] [Abstract][Full Text] [Related]
20. The year in valvular heart disease.
Rahimtoola SH
J Am Coll Cardiol; 2006 Jan; 47(2):427-39. PubMed ID: 16412873
[No Abstract] [Full Text] [Related]
[Next] [New Search]
